These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 18202755

  • 1. Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.
    Muller S, Flores-Staino C, Skyldberg B, Hellström AC, Johansson B, Hagmar B, Wallin KL, Andersson S.
    Int J Oncol; 2008 Feb; 32(2):333-40. PubMed ID: 18202755
    [Abstract] [Full Text] [Related]

  • 2. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ.
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [Abstract] [Full Text] [Related]

  • 3. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM.
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM, Wang D, Kim Y, Rubenstein LM, Lee JH, Haugen TH, Turek LP.
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [Abstract] [Full Text] [Related]

  • 6. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
    Wentzensen N, du Bois A, Kommoss S, Pfisterer J, von Knebel Doeberitz M, Schmidt D, Kommoss F.
    Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p16INK4A expression in cervical premalignant and malignant lesions.
    Lambert AP, Anschau F, Schmitt VM.
    Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
    [Abstract] [Full Text] [Related]

  • 10. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S, Scheiden R, Dreier K, Laich A, Müller-Holzner E, Pircher H, Morandell D, Stein I, Viertler HP, Santer FR, Widschwendter A, Even J, Jansen-Dürr P, Capesius C, Zwerschke W.
    Clin Cancer Res; 2007 Dec 01; 13(23):7067-72. PubMed ID: 18056184
    [Abstract] [Full Text] [Related]

  • 11. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
    Horikoshi M, Kina K, Ishi K, Izumi H, Kunii Y, Nojima M.
    Rinsho Byori; 2005 Jun 01; 53(6):494-8. PubMed ID: 16026074
    [Abstract] [Full Text] [Related]

  • 12. [Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer].
    Zhao XL, Cheng SX, Kong XD.
    Ai Zheng; 2007 May 01; 26(5):480-3. PubMed ID: 17672936
    [Abstract] [Full Text] [Related]

  • 13. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, Quattrone P, Locati LD, Bergamini C, Olmi P, Pierotti MA, Pilotti S.
    J Clin Oncol; 2006 Dec 20; 24(36):5630-6. PubMed ID: 17179101
    [Abstract] [Full Text] [Related]

  • 14. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia.
    Hashi A, Xu JY, Kondo T, Hashi K, Yuminamochi T, Nara M, Murata S, Katoh R, Hoshi K.
    Int J Gynecol Pathol; 2006 Apr 20; 25(2):187-94. PubMed ID: 16633071
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
    Volgareva GM, Zavalishina LE, Andreeva IuIu, Shtil' AA, Frank GA.
    Arkh Patol; 2008 Apr 20; 70(5):57-61. PubMed ID: 19137788
    [Abstract] [Full Text] [Related]

  • 17. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
    Missaoui N, Hmissa S, Frappart L, Trabelsi A, Ben Abdelkader A, Traore C, Mokni M, Yaacoubi MT, Korbi S.
    Virchows Arch; 2006 May 20; 448(5):597-603. PubMed ID: 16496173
    [Abstract] [Full Text] [Related]

  • 18. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.
    Horn LC, Lindner K, Szepankiewicz G, Edelmann J, Hentschel B, Tannapfel A, Bilek K, Liebert UG, Richter CE, Einenkel J, Leo C.
    Int J Gynecol Pathol; 2006 Apr 20; 25(2):182-6. PubMed ID: 16633070
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of adenocarcinoma of the cervix.
    Parker MF, Arroyo GF, Geradts J, Sabichi AL, Park RC, Taylor RR, Birrer MJ.
    Gynecol Oncol; 1997 Feb 20; 64(2):242-51. PubMed ID: 9038270
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG, Malpica A, Deavers MT, Broaddus R, Nuovo GJ, Silva EG.
    Int J Gynecol Pathol; 2007 Jul 20; 26(3):328-33. PubMed ID: 17581420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.